Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells.
about
The active human gut microbiota differs from the total microbiotaA quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasisComplementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2A comparative proteomic analysis reveals a new bi-lobe protein required for bi-lobe duplication and cell division in Trypanosoma bruceiUnveiling an abundant core microbiota in the human adult colon by a phylogroup-independent searching approachData from proteomic characterization of the role of Snail1 in murine mesenchymal stem cells and 3T3-L1 fibroblasts differentiationDifferential protein expression profiling by iTRAQ-two-dimensional LC-MS/MS of human bladder cancer EJ138 cells transfected with the metastasis suppressor KiSS-1 gene.Network-based pipeline for analyzing MS data: an application toward liver cancer.Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: a pilot study.Highly multiplexed and reproducible ion-current-based strategy for large-scale quantitative proteomics and the application to protein expression dynamics induced by methylprednisolone in 60 rats.S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.Improved reporter ion assignment of raw isobaric stable isotope labeled liquid chromatography/matrix-assisted laser desorption/ionization tandem time-of-flight mass spectral data for quantitative proteomics.De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach.Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasisiTRAQ analysis of colorectal cancer cell lines suggests Drebrin (DBN1) is overexpressed during liver metastasis.Genistein exerts anti-leukemic effects on genetically different acute myeloid leukemia cell lines by inhibiting protein synthesis and cell proliferation while inducing apoptosis - molecular insights from an iTRAQ™ quantitative proteomics study.Opportunities and challenges for nutritional proteomics in cancer prevention.Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.Proteomics signature profiling (PSP): a novel contextualization approach for cancer proteomics.Enhancing gold recovery from electronic waste via lixiviant metabolic engineering in Chromobacterium violaceum.Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.A network-based maximum link approach towards MS identifies potentially important roles for undetected ARRB1/2 and ACTB in liver cancer progression.Quantitative chemical proteomics profiling of de novo protein synthesis during starvation-mediated autophagy.Cancer proteomics.Quantitative mass spectrometry for colorectal cancer proteomics.Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.Unravelling the proteome of degenerative human mitral valves.Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis.Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in rosiglitazone-treated mice.Folate and fiber in the prevention of colorectal cancer: between shadows and the light.Detection of Nuclear Protein Profile Changes by Human Metapneumovirus M2-2 Protein Using Quantitative Differential Proteomics.Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming.Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial.
P2860
Q21135295-074D3739-CC76-4DA9-B739-7D20D998544DQ23005474-8830D45D-5B69-4FCD-B268-3C0D284F18D7Q24337403-F5435EC1-E859-47B0-BC9C-E64828839A2FQ27333138-CC04BB89-8583-490A-824F-52B98A3541C3Q28744074-09D46352-BC6B-4034-BB1F-DD9A4D586373Q30990786-BD04E9A0-9A33-4F6C-8490-F9C97ECAD37EQ33530040-57978D43-DB75-4AAC-BF34-7C907F44C2E5Q33848303-09997FBD-58FC-43C4-9D81-9FB99F414934Q33896288-CF8F45FA-3641-488E-937C-BD4725390361Q34070221-DE68C8F6-283C-4EB4-8629-905346557DE0Q34244767-3292E87D-0B47-4373-A10F-6D473A887170Q34466355-55F80229-0D40-47C3-B707-A431DDB40CB0Q34634946-382EC000-7F07-48CA-8AB7-AF1E70BA5AA2Q35006575-F9AF7460-39B2-4226-A8ED-29C3053A9571Q35115084-907EF8B4-5A25-481C-A479-3ABD41B605A2Q35238980-D268A9C0-BB11-4EE8-848E-ADBF40F256C6Q36030219-D5A0AB33-5D2C-4932-87E5-9922275F1578Q36245528-708F2872-9B00-4077-8079-A3CA1E9F5CDFQ36320993-B53BAB60-F7BF-4C9C-8514-99084F00CA44Q37025546-A27BE1C2-DE1D-4F46-B046-0155B455AA69Q37160921-07EA2FD5-8FC6-4F58-8E67-902E3CAB838AQ37201047-6B65C2F4-4C1D-4B61-8063-24291EC963C8Q37365465-FBE65660-9066-4987-985E-6B70BE47E0AAQ37994133-B2AE514B-3DC3-47B4-8A8B-3D65510A4453Q38048726-0EA0321C-C2F3-4D55-944E-D45CED163CC1Q38194582-843FC7F3-3EE2-403D-B13E-D7AB7DA55682Q38412482-695C01DB-9265-4969-986E-F8615B0A65EBQ38437443-D68B495A-E16C-47D5-8782-E6B6C212DC80Q38778051-21DFDDA5-F9D2-4D8A-87E7-D539A054DD2DQ39202347-5FF3BF50-174C-472C-BEEE-9622444818DFQ41863806-8B871969-5655-4E3F-A92B-15C54DABC843Q42906667-5D05A1A6-4DDF-498D-B9C0-2CB56C8268C2Q47160156-1E37A477-BAEF-4DF7-B322-35071461407FQ50726630-C322FBE1-FD01-416E-A306-D9D40CC1E512Q54111511-E2568559-A1E9-4A99-894D-7943A3F22049Q55260772-38FFC132-633C-428F-B251-F9A547F6B894
P2860
Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells.
@en
type
label
Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells.
@en
prefLabel
Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells.
@en
P2093
P2860
P1476
Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells.
@en
P2093
Choy Leong Hew
Hwee Tong Tan
Maxey C M Chung
Qingsong Lin
Sandra Tan
Teck Kwang Lim
P2860
P304
P356
10.1074/MCP.M700483-MCP200
P577
2008-03-14T00:00:00Z